NEFL and Huntington disease: Recent evidence, published by Byrne et al., illustrates the biomarker potential of NfL in HD, showing that plasma and CSF levels of NfL are higher in HD subjects prior to disease onset, and that baseline NfL level has independent prognostic power for subsequent disease onset, progression and brain atrophy12.